Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, Piazzale Aldo Moro 5, 00185 Rome, Italy.
Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, Piazzale Aldo Moro 5, 00185 Rome, Italy.
Int J Pharm. 2020 Jul 30;585:119467. doi: 10.1016/j.ijpharm.2020.119467. Epub 2020 Jun 1.
Since the application of nanotechnology to drug delivery, both polymer-based and lipid-based nanocarriers have demonstrated clinical benefits, improving both drug efficacy and safety. However, to further address the challenges of the drug delivery field, hybrid lipid-polymer nanocomposites have been designed to merge the beneficial features of both polymer-based and lipid-based delivery systems in a single nanocarrier. Within this scenario, this work is aimed at developing novel hybrid vesicles following the recent strategy of modifying the internal structure of liposomes. Specifically, polyethylene glycol-dimethacrylate (PEG-DMA, molecular weight 750 or 4000), was entrapped within unilamellar liposomes made of hydrogenated soybean phosphatidylcholine/cholesterol, and photo-crosslinked, in order to transform the aqueous inner core of liposomes into a soft and elastic hydrogel. After appropriate optimization of the preparation and gelation procedures, the primary objective of this work was to analyze the effect of the molecular weight of PEG-DMA on the main properties of these Gel-in-Liposome (GiL) systems. Indeed, by varying the molecular weight of PEG-DMA also its hydrophilic/lipophilic balance was modified and different arrangements of the polymer within the structure of liposomes as well as different interaction with their membrane were obtained. Both polymers were found in the inner core of the liposomes, however, the more hydrophobic PEG-DMA also formed localized clusters within the liposome membrane, whereas the more hydrophilic PEG-DMA formed a polymeric corona on the vesicle surface. Preliminary cytotoxicity studies were also performed to evaluate the biological safety of these GiL systems and their suitability as innovative materials drug delivery application.
自从将纳米技术应用于药物传递以来,基于聚合物和基于脂质的纳米载体都已经显示出了临床益处,提高了药物的疗效和安全性。然而,为了进一步解决药物传递领域的挑战,已经设计了混合的脂质-聚合物纳米复合材料,以在单个纳米载体中合并基于聚合物和基于脂质的传递系统的有益特征。在这种情况下,这项工作旨在开发新的混合囊泡,遵循最近修饰脂质体内部结构的策略。具体来说,聚乙二醇-二甲基丙烯酸酯(PEG-DMA,分子量为 750 或 4000)被包封在氢化大豆卵磷脂/胆固醇制成的单层脂质体中,并进行光交联,以便将脂质体的水相内核转化为柔软且有弹性的水凝胶。在适当优化了制备和胶凝过程后,这项工作的主要目标是分析 PEG-DMA 的分子量对这些凝胶在脂质体(GiL)系统中的主要性质的影响。事实上,通过改变 PEG-DMA 的分子量,还可以改变其亲水/亲脂平衡,并获得聚合物在脂质体结构内的不同排列以及与膜的不同相互作用。两种聚合物都被发现存在于脂质体的内核中,然而,疏水性更强的 PEG-DMA 也在脂质体膜内形成局部簇,而亲水性更强的 PEG-DMA 在囊泡表面形成聚合物冠。还进行了初步的细胞毒性研究,以评估这些 GiL 系统的生物安全性及其作为创新材料在药物传递应用中的适用性。